The Prevention of Failure to Rescue Using Early Warning Scoring

CompletedOBSERVATIONAL
Enrollment

414

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

May 31, 2010

Study Completion Date

June 30, 2010

Conditions
SepsisRenal FailurePulmonary EdemaCardio-pulmonary Arrest
Interventions
DEVICE

use of the MP5 EWS patient monitor

All patients on the study ward receive the same care in Groups 1 and 2. The only difference is the device used to collect the vital signs. In Group 2, the MP5 EWS spot check monitor (FDA approved and CE marked) is the vital signs collection device.

Trial Locations (1)

3084

Austin Hospital, Heidelberg

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Philips Healthcare

INDUSTRY